Empowering Early Intervention

An estimated 3.5 million Americans are living with Autism Spectrum Disorder (ASD). Early diagnosis is crucial, as research shows that treatment initiated during the critical brain development period can significantly improve outcomes. However, the average age of diagnosis in the US remains around 4 years old, missing this vital window.

ADT: Transforming Autism Diagnosis

ADT's disruptive technology is revolutionizing the field of autism diagnostics. Our innovative approach, developed by dedicated research scientists, enables us to diagnose ASD in infants as young as six months old with over 90% accuracy. By leveraging existing brain mapping technologies combined with a unique invention, we can compare normal brains to those affected by autism, dyslexia, and Alzheimer's, providing a powerful diagnostic tool.

Key Advantages:

• Early Detection: Identify ASD at a crucial stage in brain development, allowing for timely intervention and improved outcomes.

• Unmatched Accuracy: Diagnose ASD with over 90% accuracy, providing parents and healthcare professionals with confidence and clarity.

• Potential for Expansion: Our technology has the potential to be adapted for the diagnosis of other brain disorders and diseases, offering hope for millions.

A Brighter Future for Children with ASD

Early diagnosis and intervention can make a world of difference for children with autism. By identifying ASD at a young age, we can empower families to access the support and resources they need to help their children reach their full potential.

Pioneering a New Era of Brain Health:

ADT is committed to advancing the field of brain health. Our groundbreaking technology not only transforms autism diagnosis but also opens doors to new possibilities for understanding and treating a wide range of neurological conditions.